Korean ultrasound vendor Medison America (Hall A, #1345) has undergone a major expansion campaign since last year's conference. The Pleasanton, CA, company aspires to break out of its niche in low-end ultrasound with a series of new product introductions
Korean ultrasound vendor Medison America (Hall A, #1345) has undergone a major expansion campaign since last year's conference. The Pleasanton, CA, company aspires to break out of its niche in low-end ultrasound with a series of new product introductions at this year's meeting.
The key to Medison's growth plan is Voluson 530D, an upgraded version of the Combison 530 3-D ultrasound scanner that Medison acquired with its purchase of Kretztechnik in 1996. Medison has added an all-new 128-channel digital beamformer that uses application-specific integrated circuits (ASICs), according to Peter Klein, president and CEO of Medison America. Medison plans to market Voluson 530D as a high-end ultrasound scanner that can also do 3-D imaging, rather than as a dedicated 3-D system, Klein said.
In conventional 2-D ultrasound, Medison also has two new product introductions, both of which are based on digital ultrasound technology. SonoAce 6000 is a lower mid-range system targeted at ob/gyn and surgical applications that will sell for just under $40,000. SonoAce 8800 is a work-in-progress color Doppler scanner with a 64-channel beamformer that will sell for about $80,000. SonoAce 6000 began selling in August, while SonoAce 8800 requires FDA clearance.
Medison also has designs on the MRI market and introduced the 1-tesla Magnum scanner at last year's meeting. This year, the company will feature the addition of fast spin-echo and 3-D gradient-echo sequences for the investigational scanner. Images acquired with the company's new 3-tesla whole-body scanner in South Korea will be displayed.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.